BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE. Involvement of hypocretin neurons in multiple system atrophy. Acta Neuropathol 2007;113:75-80. [PMID: 17089135 DOI: 10.1007/s00401-006-0150-0] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Tang X, Zhou J, Xu Y. Excessive Daytime Sleepiness Is Associated With Non-motor Symptoms of Multiple System Atrophy: A Cross-Sectional Study in China. Front Neurol 2021;12:798771. [PMID: 35087473 DOI: 10.3389/fneur.2021.798771] [Reference Citation Analysis]
2 Dayan E, Sklerov M. Autonomic disorders in Parkinson disease: Disrupted hypothalamic connectivity as revealed from resting-state functional magnetic resonance imaging. Handb Clin Neurol 2021;182:211-22. [PMID: 34266593 DOI: 10.1016/B978-0-12-819973-2.00014-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lin JY, Zhang LY, Cao B, Wei QQ, Ou RW, Hou YB, Liu KC, Xu XR, Jiang Z, Gu XJ, Liu J, Shang HF. Sleep-related symptoms in multiple system atrophy: determinants and impact on disease severity. Chin Med J (Engl) 2020;134:690-8. [PMID: 33234871 DOI: 10.1097/CM9.0000000000001211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Bhattacharya A, Lenka A, Stezin A, Kamble N, Pal PK. Overview of sleep disturbances and their management in Parkinson plus disorders. Journal of the Neurological Sciences 2020;415:116891. [DOI: 10.1016/j.jns.2020.116891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Baschieri F, Cortelli P. Circadian rhythms of cardiovascular autonomic function: Physiology and clinical implications in neurodegenerative diseases. Autonomic Neuroscience 2019;217:91-101. [DOI: 10.1016/j.autneu.2019.01.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
6 Meira e Cruz M, Matoso Laranjo S, Rocha I. Hypothalamic Control of Sleep-Wake Circadian Cycle. Hypothalamus in Health and Diseases 2018. [DOI: 10.5772/intechopen.79899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Bastianini S, Silvani A. Clinical implications of basic research: The role of hypocretin/orexin neurons in the central autonomic network. Clinical and Translational Neuroscience 2018;2:2514183X1878932. [DOI: 10.1177/2514183x18789327] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
8 Black SW, Sun JD, Santiago P, Laihsu A, Kimura N, Yamanaka A, Bersot R, Humphries PS. Partial ablation of the orexin field induces a sub-narcoleptic phenotype in a conditional mouse model of orexin neurodegeneration. Sleep 2018;41. [DOI: 10.1093/sleep/zsy116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
9 Black SW, Sun JD, Santiago P, Laihsu A, Kimura N, Yamanaka A, Bersot R, Humphries PS. Partial ablation of the orexin field induces a sub narcoleptic phenotype in a conditional mouse model of orexin neurodegeneration.. [DOI: 10.1101/234765] [Reference Citation Analysis]
10 Mishima T, Kasanuki K, Koga S, Castanedes-Casey M, Wszolek ZK, Tsuboi Y, Dickson DW. Reduced orexin immunoreactivity in Perry syndrome and multiple system atrophy. Parkinsonism Relat Disord 2017;42:85-9. [PMID: 28651750 DOI: 10.1016/j.parkreldis.2017.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
11 Pillai JA, Leverenz JB. Sleep and Neurodegeneration: A Critical Appraisal. Chest 2017;151:1375-86. [PMID: 28087304 DOI: 10.1016/j.chest.2017.01.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
12 Chokroverty S, Provini F. Sleep, Breathing, and Neurologic Disorders. Sleep Disorders Medicine 2017. [DOI: 10.1007/978-1-4939-6578-6_41] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Trenkwalder C, Arnulf I, Postuma R. Parkinsonism. Principles and Practice of Sleep Medicine 2017. [DOI: 10.1016/b978-0-323-24288-2.00092-1] [Reference Citation Analysis]
14 Schneider L. Anatomy and Physiology of Normal Sleep. Sleep and Neurologic Disease 2017. [DOI: 10.1016/b978-0-12-804074-4.00001-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Ferini-strambi L, Marelli S, Combi R. Does the Type of Multisystem Atrophy, Parkinsonism, or Cerebellar Ataxia Impact on the Nature of Sleep Disorders? Curr Neurol Neurosci Rep 2016;16. [DOI: 10.1007/s11910-016-0704-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Brettschneider J, Irwin DJ, Boluda S, Byrne MD, Fang L, Lee EB, Robinson JL, Suh E, Van Deerlin VM, Toledo JB, Grossman M, Hurtig H, Dengler R, Petri S, Lee VM, Trojanowski JQ. Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type. Neuropathol Appl Neurobiol 2017;43:315-29. [PMID: 27716988 DOI: 10.1111/nan.12362] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
17 Jiang H, Huang J, Shen Y, Guo S, Wang L, Han C, Liu L, Ma K, Xia Y, Li J, Xu X, Xiong N, Wang T. RBD and Neurodegenerative Diseases. Mol Neurobiol 2017;54:2997-3006. [PMID: 27032389 DOI: 10.1007/s12035-016-9831-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
18 Thannickal TC. Hypocretin (orexin) pathology in Alzheimer’s disease. World J Neurol 2015; 5(3): 64-67 [DOI: 10.5316/wjn.v5.i3.64] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Nagaoka U, Shimizu T, Uchihara T. Leptin upregulation in advanced multiple system atrophy with hypocholesterolemia and unexpected fat accumulation. Neurol Sci 2015;36:1471-1477. [DOI: 10.1007/s10072-015-2189-y] [Reference Citation Analysis]
20 Nixon JP, Mavanji V, Butterick TA, Billington CJ, Kotz CM, Teske JA. Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev 2015;20:63-73. [PMID: 25462194 DOI: 10.1016/j.arr.2014.11.001] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 11.0] [Reference Citation Analysis]
21 Iranzo A, Santamaria J. Sleep in Neurodegenerative Diseases. Sleep Medicine 2015. [DOI: 10.1007/978-1-4939-2089-1_32] [Reference Citation Analysis]
22 Cykowski MD, Takei H, Schulz PE, Appel SH, Powell SZ. TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathol Commun 2014;2:171. [PMID: 25539830 DOI: 10.1186/s40478-014-0171-1] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
23 Neuroimaging of sleep disorders. Neuroimaging of Sleep and Sleep Disorders 2013. [DOI: 10.1017/cbo9781139088268.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Valerio J, Stoessl A. Neuroimaging of Parkinson’s disease and multiple system atrophy in patients with sleep disturbance. Neuroimaging of Sleep and Sleep Disorders 2013. [DOI: 10.1017/cbo9781139088268.041] [Reference Citation Analysis]
25 Wenning GK, Krismer F. Multiple system atrophy. Autonomic Nervous System. Elsevier; 2013. pp. 229-41. [DOI: 10.1016/b978-0-444-53491-0.00019-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
26 Shimohata T, Nakayama H, Tomita M, Ozawa T, Nishizawa M. Daytime sleepiness in Japanese patients with multiple system atrophy: prevalence and determinants. BMC Neurol 2012;12:130. [PMID: 23116490 DOI: 10.1186/1471-2377-12-130] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
27 Ferini-strambi L, Marelli S. Sleep Dysfunction in Multiple System Atrophy. Curr Treat Options Neurol 2012;14:464-73. [DOI: 10.1007/s11940-012-0189-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
28 Zanigni S, Calandra-Buonaura G, Grimaldi D, Cortelli P. REM behaviour disorder and neurodegenerative diseases. Sleep Med 2011;12 Suppl 2:S54-8. [PMID: 22136901 DOI: 10.1016/j.sleep.2011.10.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
29 Vetrugno R, Montagna P. From REM sleep behaviour disorder to status dissociatus: insights into the maze of states of being. Sleep Med 2011;12 Suppl 2:S68-71. [PMID: 22136904 DOI: 10.1016/j.sleep.2011.10.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
30 Jecmenica-Lukic M, Poewe W, Tolosa E, Wenning GK. Premotor signs and symptoms of multiple system atrophy. Lancet Neurol 2012;11:361-8. [PMID: 22441197 DOI: 10.1016/S1474-4422(12)70022-4] [Cited by in Crossref: 102] [Cited by in F6Publishing: 77] [Article Influence: 10.2] [Reference Citation Analysis]
31 Billiard M. Dysfonctionnement hypocrétinergique et troubles du sommeil. Bulletin de l'Académie Nationale de Médecine 2011;195:1567-1581. [DOI: 10.1016/s0001-4079(19)31954-5] [Reference Citation Analysis]
32 España RA, Scammell TE. Sleep neurobiology from a clinical perspective. Sleep 2011;34:845-58. [PMID: 21731134 DOI: 10.5665/SLEEP.1112] [Cited by in Crossref: 92] [Cited by in F6Publishing: 125] [Article Influence: 8.4] [Reference Citation Analysis]
33 Hauw J, Hausser-hauw C, De Girolami U, Hasboun D, Seilhean D. Neuropathology of Sleep Disorders: A Review. J Neuropathol Exp Neurol 2011;70:243-52. [DOI: 10.1097/nen.0b013e318211488e] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
34 Granata R, Wenning GK. Multiple system atrophy. Handbook of Atypical Parkinsonism 2011. [DOI: 10.1017/cbo9780511920936.004] [Reference Citation Analysis]
35 Stemberger S, Wenning GK. Modelling progressive autonomic failure in MSA: where are we now? J Neural Transm (Vienna) 2011;118:841-7. [PMID: 21221668 DOI: 10.1007/s00702-010-0576-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
36 Trenkwalder C, Arnulf I. Parkinsonism. Principles and Practice of Sleep Medicine. Elsevier; 2011. pp. 980-92. [DOI: 10.1016/b978-1-4160-6645-3.00087-6] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
37 Auger RR, Boeve BF. Sleep disorders in neurodegenerative diseases other than Parkinson's disease. Sleep Disorders. Elsevier; 2011. pp. 1011-50. [DOI: 10.1016/b978-0-444-52007-4.00020-5] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
38 Valko PO, Poryazova R. Secondary Narcolepsy. Narcolepsy 2011. [DOI: 10.1007/978-1-4419-8390-9_30] [Reference Citation Analysis]
39 Chokroverty S, Montagna P. Sueño, respiración y trastornos neurológicos. Medicina de los Trastornos del Sueño 2011. [DOI: 10.1016/b978-84-8086-733-7.00029-2] [Reference Citation Analysis]
40 Boeve BF. REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 2010;1184:15-54. [PMID: 20146689 DOI: 10.1111/j.1749-6632.2009.05115.x] [Cited by in Crossref: 419] [Cited by in F6Publishing: 450] [Article Influence: 34.9] [Reference Citation Analysis]
41 Benarroch EE, Schmeichel AM, Dugger BN, Sandroni P, Parisi JE, Low PA. Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia. Neurology 2009;73:106-12. [PMID: 19597132 DOI: 10.1212/WNL.0b013e3181ad53e7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
42 Wenning GK, Stefanova N. Recent developments in multiple system atrophy. J Neurol. 2009;256:1791-1808. [PMID: 19471850 DOI: 10.1007/s00415-009-5173-8] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 6.2] [Reference Citation Analysis]
43 Tada M, Kakita A, Toyoshima Y, Onodera O, Ozawa T, Morita T, Nishizawa M, Takahashi H. Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death. Brain. 2009;132:1810-1819. [PMID: 19429902 DOI: 10.1093/brain/awp110] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 6.3] [Reference Citation Analysis]
44 Fronczek R, Baumann CR, Lammers GJ, Bassetti CL, Overeem S. Hypocretin/orexin disturbances in neurological disorders. Sleep Medicine Reviews 2009;13:9-22. [DOI: 10.1016/j.smrv.2008.05.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
45 Chokroverty S, Montagna P. Sleep, Breathing, and Neurologic Disorders. Sleep Disorders Medicine 2009. [DOI: 10.1016/b978-0-7506-7584-0.00029-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
46 Santamaría J, Iranzo A. Multiple System Atrophy and Sleep. Sleep Medicine Clinics 2008;3:337-45. [DOI: 10.1016/j.jsmc.2008.04.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
47 Hauw JJ, Hausser-Hauw C, Hasboun D, Seilhean D. [The neuropathology of sleep in human neurodegenerative diseases]. Rev Neurol (Paris) 2008;164:669-82. [PMID: 18760429 DOI: 10.1016/j.neurol.2008.07.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
48 Iranzo A. Sleep and breathing in multiple system atrophy. Curr Treat Options Neurol 2007;9:347-53. [DOI: 10.1007/s11940-007-0020-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
49 Abdo W, Bloem B, Kremer H, Lammers G, Verbeek M, Overeem S. CSF hypocretin-1 levels are normal in multiple-system atrophy. Parkinsonism & Related Disorders 2008;14:342-4. [DOI: 10.1016/j.parkreldis.2007.08.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
50 Vetrugno R, D’angelo R, Cortelli P, Plazzi G, Vignatelli L, Montagna P. Impaired cortical and autonomic arousal during sleep in multiple system atrophy. Clinical Neurophysiology 2007;118:2512-8. [DOI: 10.1016/j.clinph.2007.08.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
51 Ozawa T. Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum. Acta Neuropathol 2007;114:201-11. [PMID: 17593377 DOI: 10.1007/s00401-007-0254-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 3.7] [Reference Citation Analysis]
52 Iranzo A. Sleep and breathing in multiple system atrophy. Curr Treat Options Neurol 2007;9:347-53. [DOI: 10.1007/bf02938541] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
53 Boeve BF. Parkinson-Related Dementias. Neurologic Clinics 2007;25:761-81. [DOI: 10.1016/j.ncl.2007.04.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
54 Martinez-rodriguez JE, Seppi K, Cardozo A, Iranzo A, Stampfer-kountchev M, Wenning G, Tolosa E, Högl B, Santamaria J, Poewe W; SINBAR (Sleep Innsbruck Barcelona) group. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy. Mov Disord 2007;22:1822-4. [DOI: 10.1002/mds.21668] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]